How to Make and Use Cannabis-Infused Honey

Market Observations: Cannabinoid Honey for Recovery

• Glycemic Efficiency: Honey delivers a dual-stage release of glucose and fructose for glycogen replenishment.
• Targeted Bioavailability: The natural sugar structure of honey may facilitate cannabinoid transport, potentially bypassing digestive delays common in lipid-heavy edibles.
• Operational Precision: Micro-dosing protocols allow for 2–5mg increments, which may support focus without significant cognitive impairment.
• Terpene Standardization: Specific profiles like Beta-Caryophyllene and Myrcene are used to support the management of exercise-induced inflammation and sleep cycles.

Functional Advantage: Why Honey Is Used as an Edible Vehicle

The athletic market demands "clean label" ingredients. Honey serves as a functional delivery vehicle with distinct metabolic characteristics.

1. Glycemic Index and Metabolic Loading

Honey contains a specific ratio of fructose and glucose. Glucose enters the bloodstream for energy output, while fructose absorbs at a different rate, providing a supply for endurance training.

2. Pharmacokinetics and Absorption

Cannabinoids are lipophilic. While honey lacks fat, it functions as a delivery matrix. Consuming cannabinoids with complex carbohydrates may mitigate first-pass metabolism in the liver. This can result in an onset time of 30–45 minutes.

3. Oxidative Stress Mitigation

High-intensity training induces cellular oxidative stress. Raw honey contains phenolic compounds and flavonoids. Combining these with the properties of CBD or THC is thought to create a synergistic effect that may support the body’s response to systemic inflammation.

Production Protocol 1: Full-Spectrum Flower Infusion

Primary Use: Supporting relaxation and the parasympathetic nervous system.

Whole-plant infusion attempts to capture the "Entourage Effect," where cannabinoids and volatile terpenes provide a comprehensive physiological response.

Technical Requirements:

• 7–14g High-CBD or 1:1 Balanced Flower: Strains like Harlequin or Cannatonic are common in the recovery space.
• 1 cup Raw, Unfiltered Honey: Raw honey retains amylase, an enzyme that may support athletes with sensitive gastrointestinal tracts.
• 1 tsp Sunflower Lecithin: This emulsifier supports uniform cannabinoid distribution and may assist with intestinal absorption.

Execution:

1. Decarboxylation: Heat flower at 240°F (115°C) for 40 minutes to activate THCA and CBDA.
2. Milling: Use a coarse grind. Fine powders can degrade the flavor profile and complicate filtration.
3. Thermal Infusion: Combine ingredients in a sealed vessel. Submerge in a water bath between 160°F and 170°F.
4. Temperature Limits: Never exceed 180°F. Excessive heat may degrade raw honey enzymes and volatile terpene content.
5. Duration: Infuse for 4 hours, agitating every 30 minutes.
6. Filtration: Strain through high-micron cheesecloth while warm to maximize yield.

Production Protocol 2: Precision Tincture Integration

Primary Use: Pre-competition focus.

Competitive environments often require exact dosing. Tincture-based infusions help eliminate the potency variables found in flower-based batches.

Execution:

1. Double-Boiler Thinning: Warm 1/2 cup of honey until viscosity decreases.
2. Calculated Titration: Add lab-tested tincture based on specific milligram requirements.
3. Homogenization: Whisk for 120 seconds to ensure even distribution.
4. Ethanol Evaporation: If using alcohol-based tinctures, spread the honey on a flat surface for 24 hours to allow the carrier solvent to evaporate.

Terpene Matrix: Strategic Strain Selection

Matching terpene profiles to specific athletic phases may help optimize results.

Potency Analytics and Safety Standards

Athletes may possess higher metabolic rates, leading to faster cannabinoid processing. Standardized dosing is essential for maintaining training schedules.

Potency Calculation (Flower Infusion):

• Input: 7g flower at 20% THC = 1,400mg total potential THC.
• Efficiency: Factoring 20% loss during decarb/infusion = 1,120mg net.
• Yield: 1,120mg per cup (48 tsp) = ~23.3mg THC per teaspoon.

A 23mg dose may be excessive for active training. The recommended starting point for recovery is 1/4 teaspoon (approx. 5.8mg).

Performance-Optimized Recipes

1. Endurance Drizzle (Pre-Training)

Incorporate 1 teaspoon (2-5mg) of infused honey into green tea 45 minutes prior to aerobic exertion. The caffeine-cannabinoid stack may mitigate central nervous system fatigue.

2. Inflammation Protocol (Post-Training)

Combine 1 teaspoon of High-CBD honey with coconut water and collagen peptides. CBD may interact with CB2 receptors to support the body’s management of post-exertion inflammatory markers.

3. Parasympathetic Nightcap (Sleep Recovery)

Mix 1 teaspoon of Myrcene-rich honey into chamomile tea to support the shift from a sympathetic (stress) state to a parasympathetic (recovery) state.

Storage and Quality Preservation

• UV Protection: Light degrades THC into CBN, which may increase sedative properties. Use amber glass storage.
• Thermal Stability: Store at room temperature. If crystallization occurs, use a warm water bath. Do not use microwave radiation, as it may compromise the molecular integrity of the honey.
• Traceability: Label all containers with strain type, date of production, and mg/ml concentration.

Regulatory Compliance (WADA/USADA)

Professional and collegiate athletes must operate within World Anti-Doping Agency (WADA) guidelines. CBD is removed from the prohibited list, but THC remains banned in-competition. Trace amounts in full-spectrum products can trigger positive tests. Athletes subject to testing should utilize 99% pure CBD isolate for infusions to support compliance.

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

2. Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN. (2016). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 20(6):936-48. PubMed

3. Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV. (1997). Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. 14(1):7-14. PubMed

4. Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. (2013). Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol. 75(2):323-33. PubMed